Insider Selling: Oscar Health (NYSE:OSCR) CEO Sells 615,142 Shares

Posted by on Jun 29th, 2026

Oscar Health, Inc. (NYSE:OSCR – Get Free Report) CEO Mark Bertolini sold 615,142 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $28.61, for a total value of $17,599,212.62. Following the completion of the sale, the chief executive officer directly owned 9,581,734 shares of the company’s stock, valued at $274,133,409.74. The trade was a 6.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Down 1.4%

NYSE:OSCR traded down $0.42 on Monday, hitting $29.37. The stock had a trading volume of 5,787,135 shares, compared to its average volume of 7,824,008. The business’s fifty day moving average is $23.03 and its 200 day moving average is $17.37. The company has a market cap of $8.85 billion, a PE ratio of -49.78, a P/E/G ratio of 2.08 and a beta of 2.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $30.66.

Oscar Health (NYSE:OSCR – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter in the previous year, the company posted $0.92 earnings per share. The company’s quarterly revenue was up 52.6% on a year-over-year basis. On average, equities research analysts expect that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have commented on OSCR. Wolfe Research began coverage on Oscar Health in a report on Tuesday, May 5th. They set a “peer perform” rating for the company. Jefferies Financial Group raised Oscar Health from an “underperform” rating to a “hold” rating and increased their price target for the company from $10.00 to $16.00 in a research report on Monday, April 20th. UBS Group increased their target price on shares of Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Finally, Weiss Ratings lowered shares of Oscar Health from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $20.78.

Get Our Latest Research Report on Oscar Health

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Oscar Health by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock valued at $297,477,000 after buying an additional 540,851 shares during the period. Geode Capital Management LLC grew its stake in shares of Oscar Health by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock worth $68,964,000 after acquiring an additional 116,430 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH raised its stake in Oscar Health by 1,097.8% in the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock valued at $3,418,000 after acquiring an additional 218,022 shares during the period. BIT Capital GmbH raised its stake in Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after acquiring an additional 5,227,152 shares during the period. Finally, Farallon Capital Management LLC boosted its position in Oscar Health by 146.5% during the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

About Oscar Health

(Get Free Report)

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

Featured Stories

Insider Buying and Selling by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.